ask="6.29"
ask_size="100"
average_daily_volume="338531"
bid="3.31"
bid_size="3000"
book_value="3.74"
change="+0.24"
change_from_200_day_moving_average="1.54"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-6.69"
change_From_52_week_low="0.80"
change_in_percent="+5.93%"
close="4.29"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-41.42M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.03"
ex_dividend_date="N/A"
float_shares="13899000"
high="4.32"
high_52_weeks="10.98"
last_trade_date="2/27/2017"
last_trade_price="4.29"
last_trade_size="9196"
last_trade_time="4:00pm"
low="4.01"
low_52_weeks="3.49"
market_capitalization="96.74M"
moving_average_200_day="2.75"
moving_average_50_day="4.20"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+55.75%"
percent_change_from_50_day_moving_average="+2.24%"
percent_change_from_52_week_high="-60.93%"
percent_change_from_52_week_low="+22.92%"
previous_close="4.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.08"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22551000"
short_ratio="2.62"
stock_exchange="NMS"
symbol="CASC"
volume="265693"
weeks_range_52="3.49 - 10.98"
